Use of cannabinoid-based medicine among older residential care recipients diagnosed with dementia: study protocol for a double-blind randomised crossover trial

DiscussionThe study design has been informed by medical professionals and key stakeholders, including those working in the residential aged-care industry to ensure patient safety, collection of non-invasive measures, and methodological rigor and study feasibility.Trial registrationAustralian New Zealand Clinical Trials Registry,ACTRN12619000474156. Registered on 21 March 2019
Source: Trials - Category: Research Source Type: clinical trials